NewLink Genetics Company
NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.
Funding Status:
IPO
Industry:
Whole-Cell Antigens
Investors Number:
5
Last Funding Date:
2009-07-21
Founded Date:
1999-01-01
Headquarters:
Ames, Iowa, United States
Total Funding:
33594000
Last Funding Type:
Series D
Employee Number:
51-100